Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts

被引：8

作者：

Langabeer, Stephen E. ^{[1
]}

Crampe, Mireille ^{[1
]}

Kelly, Johanna ^{[2
]}

Fadalla, Kamal ^{[3
]}

Connaghan, Gerard ^{[3
]}

Conneally, Eibhlin ^{[4
]}

机构：

[1] St James Hosp, Cent Pathol Lab, Dublin 8, Ireland

[2] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin, Ireland

[3] St Vincents Univ Hosp, Dept Haematol, Dublin 4, Ireland

[4] St James Hosp, Dept Haematol, Dublin 8, Ireland

来源：

LEUKEMIA RESEARCH | 2010年 / 34卷 / 08期

关键词：

CHRONIC MYELOGENOUS LEUKEMIA; IMATINIB; RESISTANT;

D O I：

10.1016/j.leukres.2010.02.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E204 / E205

页数：2

共 9 条

[1] Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib [J].

Breccia, Massimo ;

Palandri, Francesca ;

Iori, Anna Paola ;

Colaci, Elisabetta ;

Latagliata, Roberto ;

Castagnetti, Fausto ;

Torelli, Giovanni Fernando ;

Usai, Sara ;

Valle, Veronica ;

Martinelli, Giovanni ;

Rosti, Gianantonio ;

Foa, Robin ;

Baccarani, Michele ;

Alimena, Giuliana .

LEUKEMIA RESEARCH, 2010, 34 (02) :143-147

[2]

Colla S, 2004, HAEMATOLOGICA, V89, P611

[3] Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation [J].

Corm, S. ;

Renneville, A. ;

Rad-Quesnel, E. ;

Grardel, N. ;

Preudhomme, C. ;

Quesnel, B. .

LEUKEMIA, 2007, 21 (11) :2376-+

[4] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J].

Gabert, J ;

Beillard, E ;

van der Velden, VHJ ;

Bi, W ;

Grimwade, D ;

Pallisgaard, N ;

Barbany, G ;

Cazzaniga, G ;

Cayuela, JM ;

Cavé, H ;

Pane, F ;

Aerts, JLE ;

De Micheli, D ;

Thirion, X ;

Pradel, V ;

González, M ;

Viehmann, S ;

Malec, M ;

Saglio, G ;

van Dongen, JJM .

LEUKEMIA, 2003, 17 (12) :2318-2357

[5] A novel BCR-ABL, fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia [J].

Hochhaus, A ;

Reiter, A ;

Skladny, H ;

Melo, JV ;

Sick, C ;

Berger, U ;

Guo, JQ ;

Arlinghaus, RB ;

Hehlmann, R ;

Goldman, JM ;

Cross, NCP .

BLOOD, 1996, 88 (06) :2236-2240

[6] Current Status and Perspectives of Tyrosine Kinase Inhibitor Treatment in the Posttransplant Period in Patients with Chronic Myelogenous Leukemia (CML) [J].

Klyuchnikov, Evgeny ;

Kroeger, Nicolaus ;

Brummendorf, Tim H. ;

Wiedemann, Bettina ;

Zander, Axel Rolf ;

Bacher, Ulrike .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (03) :301-310

[7] Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib [J].

Ritchie, David S. ;

McBean, Michelle ;

Westerman, David A. ;

Kovalenko, Sergey ;

Seymour, John F. ;

Dobrovic, Alexander .

BLOOD, 2008, 111 (05) :2896-2898

[8]

Roti G, 2005, HAEMATOLOGICA, V90, P1139

[9] Chronic Myelogenous Leukemia with the e6a2 BCR-ABL and Lacking Imatinib Response: Presentation of Two Cases [J].

Vefring, Hege K. ;

Gruber, Franz X. E. ;

Wee, Line ;

Hovland, Randi ;

Hjorth-Hansen, Henrik ;

Dahl, Tobias Gedde ;

Meyer, Peter .

ACTA HAEMATOLOGICA, 2009, 122 (01) :11-16

← 1 →